concentrations higher than 5.75 mM(l g/liter" 1) did not inhibit growth but specifically prevented antibiotic formation. Changes in the pHmediumand carbon or nitrogen depletion were excluded as the cause of antibiotic underproduction. Theuse of a phosphate analogue, a protein synthesis inhibitor and the profiles of differential rate of antibiotic production suggested that phosphate itself transiently repressed gentamicin formation. Phosphate affected the formation of 2-deoxystreptamine from 2-deoxyinosose, a none phosphorylated substrate.
Gentamicinis an antibiotic complexcontaining three major aminoglycoside componentsreferred to as C-l, C-la and C-2. Amongaminoglycosides, gentamicin is the antimicrobial agent of choice for the treatment of several classes of infections caused by Escherichia coli, Proteus and PseudomonasX). Even though gentamicin has an industrial importance, little information is available with respect to its fermentative production and the factors and conditions that control its biosynthesis.
Inorganic phosphate has long been known to suppress the biosynthesis of many antibiotics and other secondary metabolites2). In these examples orthophosphate either inhibited or repressed dephosphorylation reactions or synthetases in which orthophosphate is neither a substrate nor a product. During the biosynthesis of other aminoglycoside antibiotics such as streptomycin, neomicin and butirosin A, biologically inactive phosphorylated intermediates are formed which later are enzymatically dephosphorylated to yield bioactive products. In these examples, dephosphorylation reactions are phosphate inhibited and repressed with the subsequent accumulation of streptomycin-6-phosphate, neomicin-6-phosphate and butirosin A-6'-diphosphate respectively3~5). Our group have been involved in studies on the factors and conditions controlling gentamicin formation6). In this antibiotic, phosphate regulation has been suggested by the use of phosphate-trapping agents in Micromonospora echinospora subsp. echinospora7). Considering that amongaminoglycosides antibiotics, gentamicin biosynthesis does not includes dephosphorylation reactions, we endeavored identify the mechanismof phosphate regulation involved in this antibiotic. This paper describes the effect of phosphate on the synthesis of gentamicin and presents data indicating that phosphate transiently represses antibiotic formation by preventing the synthesis of 2-deoxystreptamine from 2-deoxyinosose, a none phosphorylated compound. FeSO4 H2O, lg CaCO3, 0.003g ZnSO4 H2O, 0.001g MnSO4à"4H2O, 0.0001g CoCl2-6H2O and the desired K2HPO4concentration, per 100 ml distilled water. After preparation, the CD medium was adjusted to pH 6.8 with 1 n HC1and autoclaved at 22 atm for 20 minutes. Sucrose was sterilized separately and added before inoculation. Fermentations were carried out at 29°C for 7 days on a rotary shaker at 175 rpm.
Additions to the Fermentation. After 48 hours fermentation, chloramphenicol, arsenate, antibiotic precursors and phosphate, previously filter sterilized (with Millipore filters type HAWP)were added to cultures growing in the CD medium described above with 1.42mMphosphate. The cultures were returned to the shaker and at desired times 2 ml samples were withdrawn for further analysis.
Assay of Gentamicin and Phosphate Determination At specified intervals, the production of antibiotic was determined by an agar disk technique using Bacillus subtilis ATCC 6633 as the assay organism6). Phosphate consumption was evaluated in the culture medium (50 jj\ samples), according to Summer8*.
Growth Determination
Samples of mycelia were harvested, washed with 2 volume distilled water and placed in 2 ml of 0.3 m trichloroacetic acid. After centrifugation, the pellet was resuspended in l ml of 0.4n NaOH,and its protein concentration determined by the Lowry method using bovine serum albumin as standard.
Reproducibility of Results
The experiments reported were repeated at least once (two independent experiments) in duplicate and the results are meanvalues. The observed variations were consistently less than 10%.
Results and Discussion
Effect of Inorganic Phosphate Concentration M. purpurea was able to grow and produce gentamicin in a chemically defined medium containing 1.42mMinorganic phosphate. Fig. 1 shows maximumgrowth and specific antibiotic production of this microorganism in fermentations with phosphate concentrations ranging from 1.42 to 17.2mM. As shown in the figure, with the use of phosphate concentrations higher than 5.75mMan inverse correlation was found between the maximum antibiotic production and the initial phosphate concentration with a maximum effect (65% decrease) seen at ll.5mM. Therefore, the addition of ll.5mM phosphate did not inhibit growth but specifically prevented antibiotic formation. Under these conditions, no changes were observed in the pHof the medium, nor limitations in the carbon and nitrogen sources, even at 144 hours of incubation, thus excluding pHand nutrient depletion as the cause of gentamicin underproduction.
After 96 hours offermentation, phosphate was totally consumedwhen added to the mediumat 1.44 mM. On the other hand, no more than 65%consumption was observed when phosphate concentrations higher than 5.75 mMwere utilized (not shown). Nevertheless, an inverse correlation between phosphate consumed and antibiotic formed was observed (Fig. 2) .
Addition of Inorganic Phosphate During the Fermentation
In order to characterize the phosphate effect, a high ion concentration was added to cultures growing in low phosphate at 48 hours of fermentation (once the production of gentamicin had started). As seen in Fig. 3 , in contrast to the control without additional phosphate, supplementation with ll.5mM phosphate reduced the rate of antibiotic biosynthesis. As shown in the same figure, the addition of a protein synthesis inhibitor (chloramphenicol) to low phosphate fermentations, also exerted a negative effect on gentamicin production, similar to that observed at a high phosphate concentration, suggesting a repressive rather than an inhibitory action on antibiotic formation.
Cultures were grownin fermentation mediumwith phosphate ranging from 0.86 to 17.2him. Additions were done in 48 hours cultures grown in fermentation mediumwith 1.42 him phosphate.
Effect of Arsenate on Antibiotic Formation
To establish whether or not phosphate per se was responsible for this effect, a non-metabolizable phosphate analogue, sodium arsenate9), was supplied to cultures grown with low phosphate. As revealed in Fig. 3 , in contrast to a control without further addition, arsenate significantly decreased antibiotic production, but had no effect on growth. As can be seen in the same figure, the magnitude of this effect was similar to that obtained at a high phosphate concentration/ Therefore phosphate, rather than a product derived from its metabolism, seemed to be responsible for the suppression of gentamicin formation. Phosphate (ll.5him) was added at 48hours of fermentation (repressed cultures). Precursors and intermediates were added to repressed cultures at 96 hours of incubation. After 144 hours of fermentation, gentamicin was quantified in the fermentation broths.
Differential
Rate of Antibiotic Synthesis To gain more information about the phosphate effect, the microorganism was grown with low (1.42 mm) and high (1 1.5 mM)phosphate concentrations, and growth was plotted versus gentamicin production at different times during the fermentation. As can be seen in Fig. 4 , a close relationship between these parameters was observed at a low phosphate concentration. However, when a high concentration of the ion was used, this relationship was modified by an increase in the extent of growth and a delay in antibiotic production. The profile observed with high phosphate was comparable to that reported for the transient repression of /?-galactosidase and erythromycin elicited by glucose in Escherichia coli and Streptomyces erythraeus respectively.10'1 1* As pointed out by these authors, a transient repressive effect is characterized by a strong but temporary suppression in the formation of a given metabolite. Therefore, a transient repression exerted by phosphate wasconsidered as the cause of its negative effect on antibiotic formation.
Addition of Precursors of the Antibiotic Pathway In order to define the step in antibiotic formation that is affected by phosphate, we treated repressed cultures with several precursors and intermediates of the gentamicin pathway in an attempt to reverse the negative effect. L-Glutamine, D-glucosamine, D-glucosamine-6-phosphate, 2-deoxystreptamine (ranging from 5 to 30mM)and D-xylose (66 and 132mM)were employed for this purpose. These compounds were efficiently taken up by the cells, however, among them, only 2-deoxystreptamine, added at 96 hours of fermentation, was able to overcome the negative effect of high phosphate concentration (Table 1) . Therefore, the regulation observed seemed to take place at a step in the gentamicin pathway between deoxyinosose and 2-deoxystreptamine. Considering that phosphate has been reported as a regulator of someglutamine amido transferases2), there is the possibility that this ion could regulate L-glutamine: ketoscyllo-inositol amino transferase. This enzyme catalyzes the amination of deoxy-inosose and aminodeoxyinosose, precursors of2-deoxystreptamine1 2). In any case, phosphate repressed gentamicin formation in M. purpurea, by a mechanismwhich does not seems to involve dephosphorylation reactions. As far as we know this DEC. 1994 is the first report of aminoglycoside antibiotic synthetases regulated in this way. Diverse none-aminoglycoside antibiotic synthetases catalyzing reactions in which orthophosphate is neither a substrate nor a product have been reported as repressible by phosphate. These include anhydrotetracycline oxygenase in the biosynthesis of tetracycline by Streptomyces aureofaciens, /?-aminobenzoate synthase in the formation of candicidin by Streptomyces griseus and /Mactam synthetases in the production of cephalosporin by Acremoniumchrysogenum2).
